Tops & Flops Stocks
| Security ▼ | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Zosano Pharma Corp. | - | - | - | - | - | - | - |
| Zogenix Inc. | - | - | - | - | - | - | - |
| Ziopharm Oncology | 11.930% | - | - | - | - | - | - |
| Zealand Pharma A/s | 1.480% | 3.711% | 17.553% | -33.816% | -30.016% | 148.311% | - |
| XOMA Corp. | 1.520% | 3.731% | -2.113% | -2.113% | 13.008% | 51.913% | -2.250% |
| Xeris Biopharma Holdings Inc. | 5.660% | 3.680% | -10.047% | 68.466% | 76.174% | 319.086% | 71.875% |
| Xenon Pharmaceuticals Inc. | 0.520% | 3.784% | 15.663% | -3.518% | 4.348% | 10.983% | - |
| XBiotech Inc | 0.000% | 5.584% | 0.971% | -65.333% | -41.899% | -30.248% | -86.216% |
| X4 Pharmaceuticals, Inc. | -2.310% | - | - | - | - | - | - |
| Wenzhou Kangning Hospital Co Ltd | - | 0.877% | -0.862% | -18.440% | -20.139% | -20.139% | -58.029% |
| WAVE Life Sciences Ltd | 9.320% | 166.116% | 142.105% | 11.034% | 31.967% | 336.906% | 123.611% |
| Voyager Therapeutics Inc | -0.320% | 7.904% | 0.655% | -39.024% | -33.103% | -37.270% | -43.725% |
| Vivani Medical Inc. | -1.550% | 6.140% | -2.419% | -1.626% | 11.009% | -21.429% | -66.389% |
| Vitrolife AB | 0.800% | -5.669% | -2.194% | -33.191% | -33.617% | -28.481% | - |
| Vita 34 AG | -0.910% | 0.926% | -2.679% | 25.000% | 32.282% | -33.211% | -56.746% |
| Virtus Health Ltd | - | - | - | - | - | - | - |
| Virbac S.A. | -2.440% | -1.414% | 2.199% | 8.906% | 11.699% | 44.306% | 61.717% |
| Viracta Therapeutics Inc. | - | - | - | - | - | - | - |
| Viking Therapeutics Inc | 0.530% | 10.106% | 0.880% | -32.736% | -18.088% | 796.730% | 546.419% |
| ViewRay Inc | 2400.000% | - | - | - | - | - | - |
| Vericel Corp. | 0.000% | -1.852% | -4.790% | -40.000% | -41.651% | 42.537% | 48.114% |
| Verastem Inc. | 0.570% | 4.167% | 25.000% | 68.269% | 151.437% | 72.502% | -62.278% |
| Veracyte Inc. | 0.540% | -6.000% | 5.028% | -9.615% | -1.571% | 44.671% | -24.800% |
| Veloxis Pharmaceuticals As | - | - | - | - | - | - | - |
| Vectura plc | - | - | - | - | - | - | - |

